Kelleher Financial Advisors’s LENZ Therapeutics LENZ Stock Holding History

Kelleher Financial Advisors’s Portfolio LENZ Stock Details LENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$193K	Buy	34,046 +17,023	+100%	+$137K	0.03%	293
2026 Q1	$156K	Hold	17,023	–	–	0.04%	227
2025 Q4	$272K	Hold	17,023	–	–	0.06%	178
2025 Q3	$793K	Hold	17,023	–	–	0.2%	77
2025 Q2	$499K	Hold	17,023	–	–	0.17%	79
2025 Q1	$438K	Hold	17,023	–	–	0.17%	82
2024 Q4	$491K	Sell	17,023 -3,750	-18%	-$114K	0.19%	76
2024 Q3	$493K	Buy	+20,773	New	+$461K	0.19%	70

Other funds holding LENZ

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

AWG

Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

7IH

72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

Kelleher Financial Advisors's LENZ Position: Q2 2026 in Review

Kelleher Financial Advisors increased its LENZ Therapeutics (LENZ) stake by 100% in Q2 2026, buying an estimated $137K and bringing the position to 34,046 shares worth $193K. The position accounts for 0.03% of the portfolio, ranked #293.

Kelleher Financial Advisors first reported a position in LENZ in Q3 2024 and has held it in 8 quarters since. The position peaked at $793K in Q3 2025. 144 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

Kelleher Financial Advisors held 34,046 shares of LENZ Therapeutics worth $193K as of Q2 2026.
Kelleher Financial Advisors bought 17,023 LENZ Therapeutics shares in Q2 2026, an estimated $137K.
LENZ Therapeutics made up 0.03% of Kelleher Financial Advisors's portfolio in Q2 2026, its #293 holding.
Kelleher Financial Advisors first reported a position in LENZ Therapeutics in Q3 2024 and has held it in 8 quarters since.
Kelleher Financial Advisors's LENZ Therapeutics position peaked at $793K in Q3 2025.
144 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on Kelleher Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.